This content is machine translated 5th SSHO in St. Gallen How do advances in treatment translate to clinical practice? Several studies in the area of chronic lymphocytic leukemia have attracted attention in recent years, most notably, of course, the CLL11 study, which demonstrated a clear benefit of the combination…
View Post 2 min This content is machine translated Stage 2 analysis of the CLL11 study Is the chlorambucil combination with GA101 superior to that with rituximab? At the ASH Congress in New Orleans, one of the topics was the CLL11 Phase 3 trial. After showing in the last issue of InFo ONCOLOGY & HEMATOLOGY that the…
View Post 6 min This content is machine translated Chronic lymphocytic leukemia and non-Hodgkin's lymphoma Updates on the active ingredients GA101 and rituximab Three studies on chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma were discussed at the ASH in New Orleans: One was an update on the stage 1 analysis of the CLL11…
